Baxter

Contact
baxter.at
+43-1-71120-0

Baxter Healthcare GmbH

Stella-Klein-Löw-Weg 15
1020 Wien
Austria
+43-1-71120-0
baxter.at
Contact
Profile Products News
Contact

About Baxter

Baxter ist ein weltweit führender Anbieter von medizintechnischen und pharmazeutischen Produkten. Durch Anwendung und Einsatz neuester Technologien bietet Baxter Hilfe für Maßnahmen, die Leben retten und Leben erhalten.

Read more about Baxter
Facts about Baxter
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of Baxter

Product portfolio

Show all

News about Baxter

Baxter

20-May-2015 | business & finance

Baxter BioScience to Expand Global Oncology Footprint with Acquisition of Oncaspa Portfolio for Leukemia

Baxter International Inc. announced it has signed a definitive agreement to acquire the Oncaspar® (pegaspargase) product portfolio from Sigma-Tau ...

Read news
Baxter

07-Feb-2007 | business & finance

Jerini expands collaboration with Baxter to develop non-intraveneous hemophilia therapy

Jerini AG announced the expansion of their current research collaboration with Baxter AG for the development of a non-intravenous therapy for the treatment ...

Read news
Baxter

06-Feb-2007 | research and development

Kuros starts Phase II clinical trial in bone regeneration

Kuros reaches key milestone in its collaboration with Baxter

Read news
Baxter

29-Jan-2007 | research and development

BioVeris Completes Additional Vaccine License

New License Adds Neisseria meningitidis group Y and Haemophilus influenzae type b to Bioveris's Vaccine Candidate Portfolio

Read news
Baxter

18-Dec-2006 | business & finance

Lipoxen Announces $75M Agreement with Baxter to Develop New Blood Clotting Factors

Lipoxen PLC announced that the company has entered into an exclusive worldwide development and licence agreement with a subsidiary of Baxter International ...

Read news
Baxter

25-Oct-2006 | business & finance

GenOdyssee SA Announces Research Partnership with Baxter AG

GenOdyssee S.A., a biotechnology company dedicated to the discovery of novel protein therapeutic products, has entered into a research and development ...

Read news
Baxter

15-Feb-2006 | research and development

Cerus Obtains Exclusive Rights to INTERCEPT Blood System from Baxter

Cerus Corporation and subsidiaries of Baxter International Inc. announced that they have entered into a definitive agreement for Cerus to obtain Baxter¡¦s ...

Read news
Baxter

30-Jun-2005 | research and development

Acambis announces significant progress on its MVA smallpox vaccine programme with publication of Phase I trial results

Acambis plc announced an update on its programme to develop and manufacture its Modified Vaccinia Ankara ("MVA') attenuated smallpox vaccine, MVA3000, with ...

Read news
Show more news about Baxter

Here you will find Baxter Healthcare GmbH